{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:18:43Z","timestamp":1790882323153,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,1]],"date-time":"2027-04-01T00:00:00Z","timestamp":1806537600000},"content-version":"am","delay-in-days":304,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.surg.2026.110179","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:53:09Z","timestamp":1775065989000},"page":"110179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Total neoadjuvant therapy for rectal cancer: Implications for subsequent liver metastases and chemotherapy-associated liver injury"],"prefix":"10.1016","volume":"194","author":[{"given":"Kyoji","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish J.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy E.","family":"Newhook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hop S.","family":"Tran Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Wei D.","family":"Tzeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana C.","family":"Gamboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Nicolas","family":"Vauthey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1384-8927","authenticated-orcid":false,"given":"Yun Shin","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2026.110179_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.surg.2026.110179_bib2","first-page":"1","article-title":"Total neoadjuvant therapy: a shifting paradigm in locally advanced rectal cancer management","volume":"17","author":"Franke","year":"2018","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.surg.2026.110179_bib3","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.surg.2026.110179_bib4","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/bjs.5506","article-title":"Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer","volume":"93","author":"Bujko","year":"2006","journal-title":"Br J Surg"},{"key":"10.1016\/j.surg.2026.110179_bib5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.clon.2015.11.003","article-title":"Neoadjuvant treatment strategies for locally advanced rectal cancer","volume":"28","author":"Gollins","year":"2016","journal-title":"Clin Oncol"},{"key":"10.1016\/j.surg.2026.110179_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.surg.2026.110179_bib7","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.surg.2026.110179_bib8","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.annonc.2024.06.019","article-title":"Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial","volume":"35","author":"Conroy","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.surg.2026.110179_bib9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejca.2023.02.027","article-title":"Risk and location of distant metastases in patients with locally advanced rectal cancer after total neoadjuvant treatment or chemoradiotherapy in the RAPIDO trial","volume":"185","author":"Bahadoer","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.surg.2026.110179_bib10","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S2468-1253(25)00049-4","article-title":"Organ preservation after total neoadjuvant therapy for locally advanced rectal cancer (CAO\/ARO\/AIO-16): an open-label, multicentre, single-arm, phase 2 trial","volume":"10","author":"Gani","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.surg.2026.110179_bib11","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3390\/cancers15041016","article-title":"Does the gain of total neoadjuvant therapy outweigh the harm in rectal cancer? Importance of the ATRESS (neoAdjuvant Therapy-RElated shortening of survival) phenomenon: a systematic review","volume":"15","author":"Socha","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.surg.2026.110179_bib12","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.ejso.2016.02.249","article-title":"Prognostic factors after resection of colorectal liver metastases following preoperative second-line chemotherapy: impact of RAS mutations","volume":"42","author":"Passot","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.surg.2026.110179_bib13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jamcollsurg.2019.04.027","article-title":"Conditional recurrence-free survival after resection of colorectal liver metastases: persistent deleterious Association with RAS and TP53 Co-Mutation","volume":"229","author":"Kawaguchi","year":"2019","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.surg.2026.110179_bib14","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1200\/JCO.2008.17.5299","article-title":"Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases","volume":"26","author":"Blazer","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.surg.2026.110179_bib15","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1245\/s10434-006-9023-y","article-title":"Selection of patients for resection of hepatic colorectal metastases: expert consensus statement","volume":"13","author":"Charnsangavej","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2026.110179_bib16","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/ags3.12689","article-title":"Locoregional treatment for colorectal liver metastases aiming for precision medicine","volume":"7","author":"Maki","year":"2023","journal-title":"Ann Gastroenterol Surg"},{"key":"10.1016\/j.surg.2026.110179_bib17","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1245\/s10434-023-13656-4","article-title":"Hepatectomy before primary tumor resection as preferred approach for synchronous liver metastases from rectal cancer","volume":"30","author":"Maki","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2026.110179_bib18","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1200\/JCO.2010.32.6132","article-title":"High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome","volume":"29","author":"Brouquet","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.surg.2026.110179_bib19","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.6004\/jnccn.2020.7596","article-title":"A new surveillance algorithm after resection of colorectal liver metastases based on changes in recurrence risk and RAS mutation status","volume":"18","author":"Kawaguchi","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.surg.2026.110179_bib20","first-page":"93","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.surg.2026.110179_bib21","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.metabol.2015.11.008","article-title":"Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"65","author":"Brown","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.surg.2026.110179_bib22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jamcollsurg.2021.05.027","article-title":"Genomic sequencing and insight into clinical heterogeneity and prognostic pathway genes in patients with metastatic colorectal cancer","volume":"233","author":"Kawaguchi","year":"2021","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.surg.2026.110179_bib23","article-title":"Total neoadjuvant therapy versus standard therapy in locally advanced rectal cancer: a systematic review and meta-analysis of 15 trials","volume":"17","author":"Zhang","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.surg.2026.110179_bib24","doi-asserted-by":"crossref","first-page":"e1555","DOI":"10.1002\/onco.13824","article-title":"Total Neoadjuvant Therapy (TNT) versus standard neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis","volume":"26","author":"Liu","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.surg.2026.110179_bib25","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1245\/s10434-010-1166-1","article-title":"Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases","volume":"17","author":"Kishi","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2026.110179_bib26","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.3390\/cancers14174340","article-title":"Impact of preoperative chemotherapy features on patient outcomes after hepatectomy for initially unresectable colorectal cancer liver metastases: a LiverMetSurvey analysis","volume":"14","author":"Innominato","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.surg.2026.110179_bib27","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","article-title":"Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases","volume":"24","author":"Vauthey","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.surg.2026.110179_bib28","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s11605-007-0149-4","article-title":"Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome","volume":"11","author":"Pawlik","year":"2007","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.surg.2026.110179_bib29","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1245\/s10434-010-0979-2","article-title":"Predictive factors for hypertrophy of the future remnant liver after selective portal vein embolization","volume":"17","author":"de Baere","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2026.110179_bib30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s13046-023-02804-z","article-title":"Impact of chemotherapeutic agents on liver microenvironment: oxaliplatin create a pro-metastatic landscape","volume":"42","author":"Ma","year":"2023","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606026001017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606026001017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T20:12:04Z","timestamp":1779307924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606026001017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":30,"alternative-id":["S0039606026001017"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2026.110179","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Total neoadjuvant therapy for rectal cancer: Implications for subsequent liver metastases and chemotherapy-associated liver injury","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2026.110179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110179"}}